{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T13:11:58Z","timestamp":1783948318780,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.amjms.2021.08.008","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T18:34:31Z","timestamp":1632335671000},"page":"185-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis"],"prefix":"10.1016","volume":"363","author":[{"given":"Tao","family":"Pu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan-hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-mei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American college of rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis & Rheumatol"},{"issue":"6","key":"10.1016\/j.amjms.2021.08.008_bib0002","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/annrheumdis-2016-210715","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","volume":"76","author":"Smolen","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0003","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1136\/annrheumdis-2015-209057","article-title":"Certolizumab pegol in combination with dose-optimised methotrexate in DMARD-naive patients with early, active rheumatoid arthritis with poor prognostic factors: 1-year results from C-EARLY, a randomised, double-blind, placebo-controlled phase III study","volume":"76","author":"Emery","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"28","key":"10.1016\/j.amjms.2021.08.008_bib0004","doi-asserted-by":"crossref","first-page":"e3968","DOI":"10.1097\/MD.0000000000003968","article-title":"High remission and low relapse with prolonged intensive DMARD therapy in rheumatoid arthritis (PRINT): a multicenter randomized clinical trial","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0005","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/annrheumdis-2015-207511","article-title":"The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression","volume":"75","author":"Atsumi","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.amjms.2021.08.008_bib0006","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.4103\/0366-6999.213961","article-title":"Community hemodialysis in China: opportunities and challenges","volume":"130","author":"Zhou","year":"2017","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"10.1016\/j.amjms.2021.08.008_bib0007","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.semarthrit.2016.07.016","article-title":"End-stage renal disease in patients with rheumatoid arthritis","volume":"46","author":"Paudyal","year":"2017","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0008","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s13075-017-1457-z","article-title":"Chinese registry of rheumatoid arthritis (CREDIT): II. prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis","volume":"19","author":"Jin","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"1S1","key":"10.1016\/j.amjms.2021.08.008_bib0009","doi-asserted-by":"crossref","first-page":"A6","DOI":"10.1053\/j.ajkd.2019.09.003","article-title":"US renal data system 2019 annual data report: epidemiology of kidney disease in the United States","volume":"75","author":"Saran","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.amjms.2021.08.008_bib0010","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1590\/2175-8239-jbn-2018-0095","article-title":"Successful multiple-exchange peritoneal dialysis in a patient with severe hematological toxicity by methotrexate: case report and literature review","volume":"41","author":"Aristizabal-Alzate","year":"2019","journal-title":"Jornal brasileiro de nefrologia"},{"issue":"3","key":"10.1016\/j.amjms.2021.08.008_bib0011","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/00000441-200609000-00013","article-title":"Removal of methotrexate by peritoneal dialysis and hemodialysis in a single patient with end-stage renal disease","volume":"332","author":"Diskin","year":"2006","journal-title":"Am J Med Sci"},{"issue":"8","key":"10.1016\/j.amjms.2021.08.008_bib0012","first-page":"2158","article-title":"Neutropenia associated with the use of low-dose methotrexate in a peritoneal dialysis patient. Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association","volume":"19","author":"Chess","year":"2004","journal-title":"Eur Renal Assoc"},{"issue":"5","key":"10.1016\/j.amjms.2021.08.008_bib0013","first-page":"513","article-title":"Leukemoid reaction after methotrexate-induced pancytopenia in a patient undergoing continuous ambulatory peritoneal dialysis","volume":"29","author":"Sun","year":"2006","journal-title":"Chang Gung Med J"},{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0014","first-page":"81","article-title":"Clinical dilemma over low-dose methotrexate therapy in dialysis patients: a case report and review of literature","volume":"8","author":"Liu","year":"2014","journal-title":"Iran J Kidney Dis"},{"issue":"7","key":"10.1016\/j.amjms.2021.08.008_bib0015","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/art.1780330724","article-title":"Low-dose methotrexate and severe neutropenia in patients undergoing renal dialysis","volume":"33","author":"Ellman","year":"1990","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.amjms.2021.08.008_bib0016","first-page":"1424","article-title":"Severe pancytopenia caused by a single administration of low dose methotrexate in a patient undergoing hemodialysis","volume":"26","author":"Nakamura","year":"1999","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.amjms.2021.08.008_bib0017","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1002\/1529-0131(200005)43:5<1185::AID-ANR30>3.0.CO;2-V","article-title":"Renal failure: a risk factor for methotrexate toxicity","volume":"43","author":"Chatham","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.amjms.2021.08.008_bib0018","first-page":"1087","article-title":"Severe methotrexate intoxication in a haemodialysis patient treated for rheumatoid arthritis. Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association","volume":"16","author":"Boulanger","year":"2001","journal-title":"European Renal Assoc"},{"issue":"3","key":"10.1016\/j.amjms.2021.08.008_bib0019","first-page":"530","article-title":"Should low-dose methotrexate therapy be prescribed to dialysis patients? Nephrology, dialysis, transplantation: official publication of the European dialysis and transplant association","volume":"17","author":"Basile","year":"2002","journal-title":"European Renal Assoc"},{"issue":"4","key":"10.1016\/j.amjms.2021.08.008_bib0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1179\/acb.2006.028","article-title":"Methotrexate should not be used for patients with end-stage kidney disease","volume":"61","author":"Boey","year":"2006","journal-title":"Acta Clin Belg"},{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0021","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/08860220500461328","article-title":"Pancytopenia after low dose methotrexate therapy in a hemodialysis patient: case report and review of literature","volume":"28","author":"Yang","year":"2006","journal-title":"Ren Fail"},{"issue":"8","key":"10.1016\/j.amjms.2021.08.008_bib0022","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1468-3083.2006.02122.x","article-title":"Pancytopenia induced by low-dose methotrexate in a haemodialysis patient treated for bullous pemphigoid","volume":"21","author":"Seneschal","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.amjms.2021.08.008_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/RHU.0b013e3181a61f2d","article-title":"Fatal pancytopenia in a hemodialysis patient after treatment with low-dose methotrexate","volume":"15","author":"Cheung","year":"2009","journal-title":"J Clin Rheumatol"},{"issue":"3 Suppl 1","key":"10.1016\/j.amjms.2021.08.008_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1590\/abd1806-4841.20153692","article-title":"Combined acute interstitial pneumonitis and pancytopenia induced by low-dose methotrexate in a hemodialysis patient treated for bullous pemphigoid","volume":"90","author":"Liu","year":"2015","journal-title":"An Bras Dermatol"},{"issue":"1","key":"10.1016\/j.amjms.2021.08.008_bib0025","doi-asserted-by":"crossref","first-page":"E9-E12","DOI":"10.1111\/hdi.12459","article-title":"Methotrexate induced pneumatosis intestinalis under hemodialysis patient","volume":"21","author":"Mima","year":"2017","journal-title":"Hemodial Int"},{"issue":"7","key":"10.1016\/j.amjms.2021.08.008_bib0026","first-page":"578","article-title":"Pancytopenia, mucositis, and hepatotoxicity after intralesional methotrexate injection in a patient treated with peritoneal dialysis. American journal of health-system pharmacy","volume":"69","author":"Flynn","year":"2012","journal-title":"AJHP"},{"issue":"3","key":"10.1016\/j.amjms.2021.08.008_bib0027","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00228-013-1608-3","article-title":"Almost a tragedy: severe methotrexate toxicity in a hemodialysis patient treated for ectopic pregnancy","volume":"70","author":"Willner","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"issue":"2-3","key":"10.1016\/j.amjms.2021.08.008_bib0028","first-page":"129","article-title":"Case report: management of methotrexate toxicity in an anephric patient","volume":"5","author":"Langleben","year":"1982","journal-title":"Clin Invest Med"},{"issue":"7","key":"10.1016\/j.amjms.2021.08.008_bib0029","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/1756-185X.13004","article-title":"Methotrexate-induced pancytopenia: a case series of 46 patients","volume":"20","author":"Ajmani","year":"2017","journal-title":"Int J Rheumatic Dis"},{"key":"10.1016\/j.amjms.2021.08.008_bib0030","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2147\/CEOR.S188786","article-title":"Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective study","volume":"11","author":"Demiralp","year":"2019","journal-title":"Clinico Econ Outcomes Res"},{"key":"10.1016\/j.amjms.2021.08.008_bib0031","doi-asserted-by":"crossref","DOI":"10.1177\/2054358119895078","article-title":"DAMPAned methotrexate: a case report and review of the management of acute methotrexate toxicity","volume":"6","author":"Young","year":"2019","journal-title":"Canadian J Kidney Health Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921003268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962921003268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:40:50Z","timestamp":1757702450000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962921003268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0002962921003268"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2021.08.008","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancytopenia after Low-Dose Methotrexate Therapy in Two Hemodialysis Patients with Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2021.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}